Usefulness of Biopsy Specimens for Evaluating CD103
CD103
biopsy
esophageal cancer
tissue-resident memory T cells
Journal
Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
09
08
2023
revised:
07
09
2023
accepted:
11
09
2023
medline:
2
11
2023
pubmed:
1
11
2023
entrez:
1
11
2023
Statut:
ppublish
Résumé
CD103 Tissue sections were obtained from 46 patients with esophageal cancer who received neoadjuvant chemotherapy and underwent radical esophagectomy in 2017. Immunohistochemistry was performed using an anti-CD103 antibody for biopsy and surgical specimens. We examined the relationship between CD103 expression, clinicopathological features, and prognosis for each patient. T Regardless of surgical indication, we were able to determine the T
Sections du résumé
BACKGROUND/AIM
OBJECTIVE
CD103
MATERIALS AND METHODS
METHODS
Tissue sections were obtained from 46 patients with esophageal cancer who received neoadjuvant chemotherapy and underwent radical esophagectomy in 2017. Immunohistochemistry was performed using an anti-CD103 antibody for biopsy and surgical specimens. We examined the relationship between CD103 expression, clinicopathological features, and prognosis for each patient.
RESULTS
RESULTS
T
CONCLUSION
CONCLUSIONS
Regardless of surgical indication, we were able to determine the T
Identifiants
pubmed: 37909993
pii: 43/11/4823
doi: 10.21873/anticanres.16679
doi:
Substances chimiques
Immune Checkpoint Inhibitors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4823-4832Informations de copyright
Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.